Pediatric Kidney Transplantation: Cancer and Cancer Risk

Kaitlyn E Order1, Nancy M Rodig1

  • 1Division of Nephrology, Department of Pediatrics, Boston Children's Hospital, Boston, MA.

PubMed

Insights

Pediatric kidney transplantation offers survival benefits for children with end-stage kidney disease (ESKD). However, long-term immunosuppression increases cancer risk, necessitating vigilant monitoring and prevention strategies.

Area of Science:

  • Pediatric Nephrology
  • Transplantation Immunology
  • Oncology

Background:

  • Children with end-stage kidney disease (ESKD) require lifelong complex medical management.
  • Kidney transplantation is the preferred treatment for pediatric ESKD, improving survival and quality of life.
  • Long-term immunosuppression post-transplantation increases morbidity, notably cancer risk.

Purpose of the Study:

  • To review cancer incidence, types, and outcomes in pediatric kidney transplant recipients.
  • To discuss preventive strategies for cancer in this vulnerable population.

Main Methods:

  • Literature review of studies on cancer post-pediatric kidney transplantation.
  • Categorization of post-transplant cancers into lymphoproliferative disorders and solid tumors.

Main Results:

  • Cancer is a significant concern in children following kidney transplantation.
  • Common cancers include post-transplant lymphoproliferative disorders and non-lymphoproliferative solid tumors.
  • Outcomes and specific risks vary by cancer type.

Conclusions:

  • While kidney transplantation is optimal for pediatric ESKD, the associated immunosuppression poses a cancer risk.
  • Understanding cancer types, incidence, and outcomes is crucial for management.
  • Proactive surveillance and preventive measures are essential for improving long-term survival and health in these patients.